Haploidentical hematopoietic stem cell transplantation with αβTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders

Bella Bielorai*, Elad Jacoby, Nira Varda-Bloom, Daphna Hutt, Chaim Churi, Helly Vernitsky, Amos Toren

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Haploidntical hematopoietic stem cell transplantation has been increasingly used in recent years for patients without a matched donor. The αβTCR+/CD19+ depletion technique provide a graft that is enriched with CD34 cells, γδ-T-cells and natural killer. The current experience with αβTCR+/CD19+ depleted grafts in pediatric patients with malignant and non-malignant disorders, demonstrated rapid engraftment, improved immune reconstitution and low risk of GVHD. Future studies will need to define the optimal conditioning regimen in order to improve transplant outcome.

Original languageEnglish
Pages (from-to)694-697
Number of pages4
JournalBone Marrow Transplantation
Volume54
DOIs
StatePublished - 1 Aug 2019

Fingerprint

Dive into the research topics of 'Haploidentical hematopoietic stem cell transplantation with αβTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders'. Together they form a unique fingerprint.

Cite this